Prathima Patel
About Prathima Patel
Prathima Patel is the Head of WW Scientific Content and Intercon Medical Capabilities at Bristol Myers Squibb, with extensive experience in oncology and medical information.
Title
Prathima Patel is currently the Head of WW Scientific Content and Intercon Medical Capabilities at Bristol Myers Squibb. She leads key initiatives and strategies in the areas of scientific content and intercontinental medical capabilities. She has been in this role since March 2020.
Current Role at Bristol Myers Squibb
Prathima Patel heads up WW Scientific Content and Intercon Medical Capabilities at Bristol Myers Squibb. Her position involves overseeing the development and dissemination of scientific content as well as enhancing medical capabilities on an international level. She has been instrumental in driving the integration of scientific content with medical insights globally.
Previous Roles at Bristol Myers Squibb
Prathima Patel has held several key roles within Bristol Myers Squibb since starting with the company in 2009. She has served as the Oncology Access Scientific Content Lead and Director of Oncology Access Scientific Content from 2018 to 2020. Additionally, she was the Oncology Access Medical Information Lead for four years, starting in 2016. Her earlier experience includes working on oncology medical information, a role she fulfilled for 11 years.
Education and Expertise
Prathima Patel earned her Doctor of Pharmacy (Pharm.D.) degree from the University of the Sciences in Philadelphia, completing her studies from 1999 to 2005. Her strong educational background in pharmacy laid the foundation for her extensive experience and leadership roles in oncology and medical information.
Experience in Oncology
Prathima Patel has an extensive background in oncology, having been involved in various capacities related to oncology access and medical information. She has been a part of Bristol Myers Squibb’s oncology team since 2009, working in roles that range from medical information to leading scientific content. Her deep expertise in oncology has been a cornerstone of her career at Bristol Myers Squibb.